JOURNALS:
Martin, RJ, Kraft, M, Chu, HW, Berns, EA, Cassell, GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001; 107:595-601.
Kraft M, Lewis CC, Chu HW. Interleukin (IL)-4, IL-13 and dexamethasone augment airway fibroblast proliferation in asthma. J Allergy Clin Immunol 2001; 107:602-606.
Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF Jr, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN. Effect of polymorphism of the beta (2)-adrenergic receptor on the response to regular use of albuterol in asthma. Int Arch Allergy Immunol 2001; 124:183-186.
Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniak RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters S, Sorkness C, Szefler SJ. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475.
Kraft M, Hamid Q, Chrousos GP, Martin RJ, Leung DYM. Decreased steroid responsiveness at night in nocturnal asthma: is the macrophage responsible? Am J Respir Crit Care Med 2001; 163:1219-1225.
Lemanske RF, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, Drazen JM, Chinchilli VM, Craig T, Fish JE, Ford JG, Isreal E, Kraft M, Martin RJ, Nachman SA, Peters SP, Spahn JD, Szefler SJ for the National Heart, Lung and Blood Institute’s Asthma Clinical Research Network. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving Salmeterol. JAMA 2001; 285:2594-2603.
Lazarus, SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RL, Sorkness C, Kraft M, Fish JE, Peters SP, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, Nachman JD, Spahn JD, Szefler SJ for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Long acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma. JAMA 2001; 285:2583-2594.
Kraft M, Pak J, Martin RJ, Kaminsky D, Irvin CG. Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med 2001; 163:1551-1556.
Chu, HW, Kraft M, Rex MD, Martin RJ. Evaluation of blood vessels and edema in the airways of asthma patients: regulation with clarithromycin treatment. Chest 2001; 120:416-422.
Martin RJ, Kephart DK, Dyer AM, Fahy J, Kraft M for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Quality control within the Asthma Clinical Research Network. Control Clin Trials 2001; 22:207S-21S.
Zhou, Y-J, M. Chin, N. A. Cusak, L. H. Kimmel, K. S. Magnuson, J. G. Boyd, W. Lin, J. L. Roberts, A. Lengi, R. H. Buckley, R. J. Geahlen, F. Candotti, M. Gadina, P. S. Changelian, and J. J. O’Shea. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Molecular Cell 8:959.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF Jr., Mauger E, Peters SP, Sorkness CA for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Significant variability in response to inhaled corticosteroids for persistent asthma. J All Clin Immunol 2002; 1090:410-418.
Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002; 121:1782-1788.
Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich M, Boushey HA, Cherniack RM, Craig TJ, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kunselman SJ, Lazarus SC, Lemanske RF, Peters SP, Sorkness CA for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002; 165:1377-1383.
Sutherland ER, Martin RJ, Ellison MC, Kraft M. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 2002; 166:1055-61.
Huang YC, SR O’Brien and NR MacIntyre. Intrabreath diffusing capacity of the lung in normal individuals at rest and during exercise. Chest 122:177-185, 2002.
Johnson TA, RB Devlin, AJ Ghio, YCT Huang, DL Costa, CL Engle, P Bromberg and WE Cascio. Cardiopulmonary effects of nebulized residual oil fly ash in anesthetized pigs. In INIS Monograph Series, Crucial Issues in Inhalation Research – Mechanistic, Clinical and Epidemiologic. Heinrich U and Mohr U, eds. Fraunhofer IRB Verlag, Stuttgart, Germany, Page 199-212, 2002.
Samet JM, R Silbajoris,
YC Huang and I Jaspers. Transcription factor activation following exposure of an intact lung preparation to metallic particulate matter. Environ Health Perspective 110:985-990, 2002
Huang YC, SR O’Brien and NR MacIntyre. Intrabreath diffusing capacity of the lung in normal individuals at rest and during exercise. Chest 122:177-185, 2002.
Johnson TA, RB Devlin, AJ Ghio, YCT Huang, DL Costa, CL Engle, P Bromberg and WE Cascio. Cardiopulmonary effects of nebulized residual oil fly ash in anesthetized pigs. In INIS Monograph Series, Crucial Issues in Inhalation Research – Mechanistic, Clinical and Epidemiologic. Heinrich U and Mohr U, eds. Fraunhofer IRB Verlag, Stuttgart, Germany, Page 199-212, 2002.
Samet JM, R Silbajoris, YC Huang and I Jaspers. Transcription factor activation following exposure of an intact lung preparation to metallic particulate matter. Environ Health Perspective 110:985-990, 2002
Law, A.W., Reed, S.D., Sundy, J., and Schulman, K.A. 2003 Direct Costs of Allergic Rhinitis in the United States: Estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 111(2):296-300.
Sundy, J.S. 2003. Evaluating the pharmacologic alternatives in the management of arthritis pain. Managed Care Consultant 3:16-25.
Pham DM, Chu HW, Rex MD, Martin RJ, Kraft M. Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma. Ann Allergy 2003; 90:72-80.
Huang YC, J Soukup, S Harder and S Becker. Mitochondrial oxidant production and apoptosis in human alveolar macrophages induced by ROFA. Am J Physiol (Cell Physiology) 284: C24-C32, 2003.
Huang YCT, AJ Ghio, J Stonehuerner, J McGee, JD Carter, SC Grambow and RB Devlin. The role of soluble components in ambient fine particles-induced changes in human lungs and blood. Inhalation Toxicology 15:327-341, 2003
McCroy, D.C., Williams, J.W., Dolor, R.J., Gray, R.N., Reed, S.D., Sundy, J.S., and Witsell, D.L. 2003. Management of Allergic Rhinitis in the Working-Age Population. Evidence Report/Technology Assessment Number 67. (Prepared by Duke Evidence-Based Practice Center under Contract No. 290-97-0014.) AHRQ Publication No. 03-E015. Rockville, MD: Agency for Healthcare Research and Quality. March 2003.
Steinke JW, Bradley D, Arango P, Crouse CD, Frierson H, Kountakis SE, Kraft M, and Borish L. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis/nasal polyposis: Importance to eosinophilia and asthma. J Allergy Clin Immunol 2003; 111:342-349.
Lewis CC, Chu HW, Tucker A, Westcott JY, Kraft M. Platelet-derived growth factor differentially stimulates a synthetic fibroblast phenotype in severe asthma. Chest 2003; 123:428S-429S.
Sutherland ER, Kraft M, Ellison MC, Martin RJ. Altered pituitary-adrenal interaction in nocturnal asthma. J All Clin Immunol 2003; 112:52-57
Lewis CC, Sutherland ER, Moss TA, Metze TL, Rex MD, Kraft M. Interleukin-4 and interleukin-13 augment the proliferative effect of dexamethasone on distal lung fibroblasts. Chest 2003; 123: 356.
Sutherland ER, Kraft M, Rex MD, Ellison MC, Martin RJ. Hypothalamic-pituitary adrenal axis dysfunction during sleep in nocturnal asthma. Chest 2003; 405S.
Bull TM, Keith RL, Kraft M, Dempsy EC, Miller YE. Mycobacterium tuberculosis presenting as an infected pulmonary bulla. Int J Tuberc Lung Dis 2003; 7:504.
Kraft M, Martin RJ, Lazarus SC, Fahy JV, Boushey HA, Chinchilli VM, Cherniack R, Craig T, Drazen JM, Fish JE, Fagan J, Ford J, Israel E, Lemanske RF, Mauger E, Peters SP, Sorkness C, Szefler SJ, for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Airway tissue mast cells in persistent asthma: a predictor of treatment failure. Chest 2003; 124:42-50.
Sutherland ER, Martin RJ, Kraft M, Ellison M. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J All Clin Immunol 2003; 112:513-517.
Dakhama A, Kraft M, Martin RJ, Gelfand EW. Induction of Regulated upon Activation, Normal T Cells Expressed and Secreted (RANTES) and Transforming Growth Factor-{beta}1 in Airway Epithelial Cells by Mycoplasma pneumoniae. Am J Respir Cell Mol Biol 2003; 29:344-351.
Burri, PH, Carroll N, Fahy JV, Hogg J. Hyde D, Jeffery P, Kraft M. Methods for the assessment of endobronchial biopsies in clinical research: Section III. Variability and quantification. Am J Respir Crit Care Med 2003; 168:S6-S8.
Murphy TM and Chitano P. Maturational changes in airway smooth muscle shortening and relaxation—implications for asthma. In Airway Smooth Muscle and Airway Narrowing in Asthma, special issue of Respiratory Physiology and Neurobiology 137:347-359, 2003. DOI:10.1016/S1569-9048(03)00158-7
O’Shea, J. J., M. Husa, D. Li, S. Hofmann, W. Watford, J. L. Roberts, R. H. Buckley, P. Changelian and F. Candotti. 2004. Jak3 and the pathogenesis of severe combined immunodeficiency. Molecular Immunology 41:727
Roberts, J. L., A. Lengi, S. M. Brown, M. Chen, Y-J Zhou, J. J. O’Shea and R. H. Buckley. 2004. Janus kinase 3 (JAK3) deficiency: clinical, immunologic and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood 103:2009
Chitano P, Voynow JA, Pozzato V, Cantillana V, Burch LH, Wang L and Murphy TM. Ontogenesis of myosin light chain kinase content and expression in guinea pig tracheal smooth muscle. Pediatr Pulmonol, 38(6):456-464, 2004.
Bai TR, Bates JH, Brusasco V, Camoretti-Mercado B, Chitano P, Dowell M, Fabry B, Ford LE, Fredberg JJ, Gerthoffer WT, Gilbert SH, Gunst SJ, Hai CM, Halayko AJ, Hirst SJ, James AL, Janssen LJ, Jones KA, King GG, Lakser OJ, Lambert RK, Lauzon AM, Lutchen KL, Maksym GN, Meiss RA, Mitchell HW, Mitchell RW, Mitzner W, Murphy TM, Pare PD, Schellenberg RR, Seow CY, Sieck GC, Smith PG, Smolensky AV, Solway J, Stephens NL, Stewart AG, Tang DD and Wang L. On the terminology for describing the length-force relationship and its changes in airway smooth muscle. DOI:10.1152/japplphysiol.00884.2004 J Appl Physiol 97:2029-2034, 2004.
Sutherland ER, Martin RJ, Chu HW, Bowler R, Kraft M. Physiologic correlates of small airway inflammation in asthma. J All Clin Immunol 2004; 113:1046-1050.
Djukanovic R, Wilson SJ, Kraft M, Jarjour N, Steel M, Chung KF, Bao W, Fowler-Taylor A, Mathews J, Busse WW, Holgate ST, Fahy JV. The effects of recombinant humanized anti-IgE antibody (omalizumab) treatment on airways inflammation in asthma. Am J Respir Crit Care Med 2004; 170:583-593.
Huang YCT, AJ Ghio, J Stonehuerner, J McGee, JD Carter, SC Grambow and RB Devlin. The role of soluble components in ambient fine particles-induced changes in human lungs and blood. Inhalation Toxicology 15:327-341, 2003.
Kotani M, T Kotani, A Ishizaka, S Fujishima, H Koh, M Sawafuji, E Ikeda, K Moriyama, Y Kotake, H Morisaki, N aikawa, A Ohashi, K Matsushima, YCT Huang and J Takeda. Neutrophil depletion attenuates stretch-induced interleukin-8 production in normal rabbit lungs, Crit Care Med 32: 514-519, 2004.
Li ZW, JD Carter, LA Dailey, JM Soukup and YCT Huang. Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS. Environ Health Perspective 112: 201-206, 2004.
Kotani M, T Kotani, CA Piantadosi and YCT Huang. Reduced Inspiratory Flow Attenuates IL-8 Release and MAPK Activation of Lung Overstretch. Eur Resp J, 24:238-246, 2004.
Huang, YCT, ZW Li, SD Harder and JM Soukup. Apoptotic and inflammatory effects induced by different particles in human alveolar macrophages. Inhalation Toxicology 16:863-878, 2004.
Israel, E, Chinchilli, VM, Ford JG, Boushey HA, Craig T, Deykin A, Fagan JK, Fahy JV, Fish, J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CS, Szefler SJ, Wechsler ME, Weiss ST, and Drazen JM For The National Heart, Lung, And Blood Institute’s Asthma Clinical Research Network. Genotype stratified prospective trial of regularly scheduled albuterol treatment in asthma. Lancet 2004;364(9444):1505-12
Lewis CC, Chu HW, Langmack E, Sutherland ER, Tucker A, Westcott JY, Kraft M. Platelet-derived growth factor differentially stimulates a synthetic fibroblast phenotype in severe asthma. J All Clin Immunol 2005; 515:534-540.
Boushey H, Sorkness C, Sharp-King T, Sullivan, Fahy JV, Lazarus SC, Chinchilli V, Craig T, Dimango E, Deykin A, Fish JE, Kraft M, Kunselman SJ, Leone F, Lemanske RF, Martin RJ, Pesola G, Peters SP, Szefler SJ, Wechsler ME, Israel E. Regular vs. intermittent therapy for mild persistent asthma. New Engl J Med 2005; 352:1519-28.
Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola G, Peters SP, Sorkness CA, Szefler SJ, Israel E. Sputum eosinophils predict asthma control following discontinuation of inhaled corticosteroids. J All Clin Immunol 2005; 115:720-727.
Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury, B, Kraft M, Levine R, Peters SP, Sullivan EJ. Workshop on investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med 2005; 172:807-816.
Wenzel SE, Corren J, Kraft M, Meltzer EO, Nelson HS, Stoloff SW, Tashkin DP, Yawn BP. Management of asthma inprimary care settings. J Fam Pract 2005; 54:S1-32.
Lee DL, HT Chiang, SL Lin, HW Chang and YCT Huang. Heliox improves hemodynamics in mechanically ventilated COPD patients with pulsus paradoxicus. Crit Care Med. 33(5):968-973, 2005.
Huang YCT, ZW Li, LE Brighton, JL Carson, S Becker and JM Soukup. 3-Nitrotyrosine attenuates respiratory syncytial virus infection in human bronchial epithelial cell line. Am J Physiol (Lung Cell Mol Physiol) 288: L988 - L996, 2005.
Li Z, JD Carter, LA Dailey and YCT Huang. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspective, 113:1009-1014, 2005.
Becker S, LA Dailey, JM Soukup, SC Grambow, RB Devlin and YCT Huang. Seasonal variations in air pollution particle-induced inflammatory mediator release and oxidative stress. Environ Health Perspective 113: 1032-1038, 2005.
Lee DL, HT Chiang, AY-W Chang, HW Chang and YCT Huang. Beneficial effects of albuterol therapy driven by heliox vs. by oxygen in severe asthma exacerbation. Acad Emerg Med 12:820-827, 2005.
Li Z, J Stonehuerner, RB Devlin and YCT Huang. Discrimination of vanadium from zinc using gene profiling in human bronchial epithelial cells. Environ Health Perspective 113(12):1747-54, 2005.
Arredouani M, A Palecanda, H Koziel, YC Huang, A Imrich, TH Sulahian, YY Ning, Z Yang, T Pikkarainen, M Sankala, S Vargas, M Takeya, K Tryggvason and L Kobzik. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 175(9):6058-64, 2005.
McMahon TJ, GS Ahearn, MP Moya, AJ Gow, YCT Huang, BP Luchsinger, R Nudelman, Y Yan, AD Krichman, TM Bashore, RM Califf, DJ Singel, CA Piantadosi, VF Tapson and JS Stamler. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci 102(41):14801-6, 2005
Schiffman, S.S., Studwell, C.E., Landerman, L.R., Berman, K., Sundy, J.S. 2005. Symptomatic effects of exposure to diluted air sampled from a swine confinement atmosphere on healthy human subjects. Environ Health Perspect 113(5):567-76.
Savage, C, E.W. St. Clair, and J.S. Sundy. 2005. Emerging treatments for rheumatoid arthritis: update. Consultant 45:984-995.
Chitano P, Worthington CL, Jenkin JA, Stephens NL, Gyapong S and Murphy TM. Ontogenesis of myosin light chain phosphorylation in guinea pig tracheal smooth muscle. Pediatr Pulmonol 39:108-116, 2005.
Wang L, Chitano P and Murphy TM. Maturation of guinea pig tracheal strip stiffness. Am J Physiol: Lung Cell Mol Physiol 289:L902-908, 2005. DOI June 8, 2005; 10.1152/ajplung.00005.2005.
Wang L, Chitano P and Murphy TM. Length oscillation induces force potentiation in infant guinea pig airway smooth muscle. Am J Physiol: Lung Cell Mol Physiol 289:L909-L915, 2005. DOI 10.1152/ajplung.00128.2005
Chitano P, Wang L and Murphy TM. Mechanisms of airway smooth muscle relaxation during maturation. Special Issue on “Models of Smooth Muscle Contraction”. Can J Physiol Pharmacol 83:833-840, 2005.
Wang L, Chitano P and Murphy TM. A maturational model for the study of airway smooth muscle adaptation to mechanical oscillation. Special Issue on “Models of Smooth Muscle Contraction”. Can J Physiol Pharmacol 83:817-824, 2005.
Lands L, Allen J, Cloutier M, Leigh M, McColley S, Murphy T and Wilfong B. ATS consensus statement: Research opportunities and challenges in pediatric pulmonology. Am J Resp Crit Care Med 172:776-780, 2005.
Huang YC and AJ Ghio. Vascular effects of ambient pollutant particles and metals. Current Vasc Pharmcol 4:199-203, 2006.
Huang YCT, SR O’Brien, J Vredenburgh, RJ Folz, NR MacIntyre. Intrabreath analysis of carbon monoxide uptake during exercise in patients at risk for lung injury. Resp Med 100:1226-1233, 2006.
Huang YCT, MA Bassett, D Levin, T Montilla and AJ Ghio. Acute phase reaction in healthy volunteers after bronchoscopy with lavaged. Chest 129:1565-1569, 2006.
Li Z, X Hyseni, JD Carter, LA Dailey and
YCT Huang. Pollutant particles enhanced hydrogen peroxide production from NADPH oxidase and mitochondria in human pulmonary artery endothelial cells.
Am J Physiol (Cell Physiology) 291: C357-C365, 2006.
Wechsler ME, Lehman E, Lazarus SC, Lemanske RF, Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Martin RJ, Peters SP, Szefler SJ, Israel E. ß-adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Criti Care Med 2006;173:519-526
Fouty B, Moss T, Solodushko V, Kraft M. Dexamethasone can stimulate G1-S cell cycle transition in human airway fibroblasts in asthma. Eur Respir J 2006; 27:1160-1167.
Kraft M, Hamid QA. Mycoplasma and severe asthma. J All Clin Immunol 2006; 117:1197-98
Kraft M, Cairns C, Pak J, Ellison M, Irvin C, Wenzel SE. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006; in press.
Deykin A, Weschler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, Lazarus SC, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szelfler SJ, Israel E. Combination therapy with a long acting ß-agonist and a leukotriene receptor antagonist in mild-moderate asthma. Am J Respir Crit Care Med 2006; in press.
Kodavanti UP, MC Schladweiler, AD Ledbetter, RV Ortuno, M Suffia, P Evansky, JH Richards, RH Jaskot, R Thomas, ED Karoly, YCT Huang, DL Costa, PS Gilmour and KE Pinkerton. The spontaneously hypertensive rat: an experimental model of sulfur dioxide-induced airways disease. Toxicol Sci, in press, 2007.
Karoly ED, ZW Li, LA Dailey, X Hyseni, JM. Samet and YCT Huang. Transcriptional profiling in human pulmonary artery endothelial cells following ultrafine particle exposure. Environ Health Perspective. in press, 2007.
Yang LY, YCT Huang and NR MacIntyre. Patient-ventilator synchrony during pressure vs. flow targeted small tidal volume assisted ventilation. J Crit Care, in press, 2007.
REVIEWS:
Kraft M. LTRA Inhibition of Exercise Induced Bronchoconstriction. Postgraduate Medicine Special Report, McGraw-Hill Company, Inc. September 2000:32-39.
Kraft M. Guest Editor, Seminars in Respiratory Medicine, “Asthma”. 2002; 23(4).
Martin RJ, Kraft M. Introduction: asthma in the new millennium. Chest 2003; 123:339S.
Hauswirth, D.W., and Sundy JS. 2004. Bioaerosols and innate immune responses in respiratory diseases. Curr Opinion All Clin Immunol 4:361-366.
Ghio AJ and YC Huang. Exposure to concentrated ambient particles (CAPs): a review. Inhalation Toxicology 16:53-59, 2004.
Huang YC. Monitoring Oxygen Delivery in the Critically Ill. Chest (suppl) 128:554S-560S, 2005.
Busse W, Kraft M. Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 2005; 127:1312-1326.
Kraft M. The Role of Bacterial Infections in Asthma. Clin Chest Med 2000; 21; 301-313.
Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Pro/Con Editorial. Am J Respir Crit Care Med 2006; 174:238-244.
BOOKS AND BOOK CHAPTERS:
Kraft M. The Role of Bacterial Infections in Asthma. Clin Chest Med 2000; 21:301-313.
Vianna EO, Kraft M, Martin RJ. Asthma. In: Parsons PE, Heffner JE eds. Pulmonary and Respiratory Therapy Secrets. Philadelphia: Hanley & Belfus, 2001; 96-101.
Pham D, Kraft M. “Chronic Infection and Severe Asthma”. In: Leung DYM, Szefler SJ eds. Severe Asthma: Pathogenesis and Clinical Management. Marcel Dekker, New York, 2001; 303-318.
Huang YC. Arterial blood Gases. In: Respiratory Care: Principles and Practice, Hess DR, MacIntyre NR, Mishoe SC, Galvin WF, Saposnick AB, Adams AB (Eds). WB Saunders Company, Philadelphia, PA, pp362-396, 2002.
Kraft M. Asthma. Semin Respir Med 2002; 23:315-316.
Sutherland ER, Kraft M. Crapo JD. “Diagnosis and Treatment of Asthma”, Textbook of Pulmonary Disease, 7th ed. Lippincott Raven, 2003; 179-202.
Sundy, J.S., Jaffe, G., and McCallum, R.M. 2004. Management of extra-articular manifestations. In: Haynes, B.F., Pisetsky, D.S., and St. Clair, E.W., eds. RA: Textbook of Rheumatoid Arthritis. Lippincott, Williams, and Wilkins. pp 483-95.
Sundy, J.S. 2004. Nonsteroidal anti-inflammatory drugs. In: Koopman, W.J., and Moreland, L.W., eds. Arthritis and Allied Conditions: A Textbook of Rheumatology. 15th edition. Lippincott, Williams, Wilkins. pp. 679-704.
Williams LW, Roberts JL. “Immunodeficiency Disorders.” In: Lieberman PL, Blaiss MS (ed.), Atlas of Allergic Diseases, 2nd edition, 2005, Current Medicine, Philadelphia
Lugogo N, Kraft M. “ Epidemiology of Asthma.” Clin Chest Med, 2006, 27:1-15.
Slade D, Kraft M. Airway Remodeling in Asthma. Clin Chest Med, 2006, 27:71-85.
Castro M, Kraft M eds. Clinical Asthma. Elsevier, New York. (In preparation, 2006)
Kraft M. Approach to the Patient with Respiratory Disease. Cecil’s Textbook of Internal Medicine. Goldman L.(ed). In press